US vaccines start late-stage human trial
If the trial is successful, the companies will seek regulatory approval as early as October.
If the trial is successful, the companies will seek regulatory approval as early as October.
A final trial is expected to be completed in the next three months.
Britain said it was the first such deal that Pfizer and BioNTech had agreed for the supply of their vaccine, ...
The test was developed under a partnership between Oxford University and the leading diagnostics firms of the UK.
Biotech company that developed vaccine aims to start final phase of testing soon.
US National Institute of Allergy and Infectious Diseases Director expressed that global collaboration and transparency are critical to deal with ...
China is behind eight of the 19 vaccine candidates in human trials, with Sinovac’s experimental shot and one jointly developed ...
Chair of the UK Government Vaccine Taskforce said that excluding the Oxford vaccine program, she hoped there would be a ...
The country's first vaccine got the approval for human trials from the country’s drug regulator, as the number of coronavirus-related ...
An increase in cases in China’s capital Beijing has forced authorities to study the genome of a possible new strain.